Press Releases LUMIBIRD

Equities

Market Closed - Euronext Paris Other stock markets 11:35:04 2024-06-10 am EDT			5-day change	1st Jan Change
12 ^EUR	-4.38%		-6.61%	-1.48%

May. 23	Lumibird: strategic plan confirms objectives	CF
May. 03	Lumibird launches product for dry eyes	CF

LUMIBIRD PRESENTS ITS NEW STRATEGIC PLAN	May. 22	GL
LUMIBIRD MEDICAL OBTAINS CE MARKING FOR C.DIAG®, A PLATFORM TO HELP DIAGNOSE DRY EYE	May. 03	GL
LUMIBIRD MEDICAL OBTAINS CE MARKING FOR C.DIAG®, A PLATFORM TO HELP DIAGNOSE DRY EYE	May. 03	AQ
LUMIBIRD: PUBLICATION OF THE 2023 UNIVERSAL REGISTRATION DOCUMENT INCLUDING THE ANNUAL FINANCIAL REPORT	Apr. 05	GL
LUMIBIRD: ACCESS TO PREPARATORY DOCUMENTS FOR THE COMBINED GENERAL MEETING ON APRIL 29, 2024	Mar. 25	GL
LUMIBIRD: ANNUAL RESULTS 2023	Mar. 12	GL
LUMIBIRD : nombre d'actions au 29 février 2024	Mar. 07	PU
LUMIBIRD RECEIVES LASER RANGEFINDER ORDERS FOR CV90	Feb. 29	GL
LUMIBIRD: 2023 REVENUES AT €203.6M	Jan. 29	GL
LUMIBIRD: FINANCIAL COMMUNICATIONS AGENDA	Jan. 26	GL
LUMIBIRD: FINANCIAL COMMUNICATIONS AGENDA	Jan. 26	AQ
LUMIBIRD ADJUSTS ITS 2023 GROWTH TARGET	Dec. 14	GL
LUMIBIRD ADJUSTS ITS 2023 GROWTH TARGET	Dec. 14	AQ
LUMIBIRD CLARIFIES ITS INTENTIONS REGARDING CILAS	Nov. 24	GL
LUMIBIRD CLARIFIES ITS INTENTIONS REGARDING CILAS	Nov. 24	AQ
LUMIBIRD : QUANTEL MEDICAL ONE OF THE FIRST WINNERS OF THE FRANCE 2030 “MEDICAL IMAGING” CALL FOR PROJECTS	Nov. 15	GL
LUMIBIRD: REVENUES FOR THE FIRST 9 MONTHS OF 2023: €139.0M (+11%)	23-10-24	GL
LUMIBIRD: REVENUES FOR THE FIRST 9 MONTHS OF 2023: €139.0M (+11%)	23-10-24	AQ
LUMIBIRD: 2023 HALF-YEAR EARNINGS	23-09-26	GL
LUMIBIRD: MAJOR CONTRACT SIGNED FOR LASER RANGEFINDERS FOR DEFENCE APPLICATIONS	23-09-14	GL

No results for this search